A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.

 
Web www.patentalert.com

< Inhibiting the development of tolerance to and/or dependence on an addictive substance

< (E)-styryl sulfone anticancer agents

> Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

> Method of making iron(III)gluconate complex

~ 00242